The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study

• Main Authors: Nuttakant Nontawong (Author), Taweegrit Siripongboonsitti (Author), Kriangkrai Tawinprai (Author), Mana Boonpratoom (Author), Nawin Krailassiri (Author), Chayaporn Boonkhum (Author), Kamonwan Soonklang (Author), Yong Poovorawan (Author), Nithi Mahanonda (Author)
• Format: Book
• Published: BMC, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Coronavirus disease 2019 (COVID-19) causes life-threatening pneumonia. Convalescent plasma therapy (CPT) is expected to be the effective COVID-19 treatment for passive immunity. The high neutralizing antibodies titer of CPT is needed to prove the benefit in early developed severe...